Terms: = Prostate cancer AND FUBP1, FBP, 8880, ENSG00000162613, FUBP
15 results:
1. Development and validation of a nomogram to predict cancer-specific survival in nonsurgically treated elderly patients with prostate cancer.
Zhang Z; Cai Q; Wang J; Yao Z; Ji F; Hang Y; Ma J; Jiang H; Yan B; Zhanghuang C
Sci Rep; 2023 Oct; 13(1):17719. PubMed ID: 37853026
[TBL] [Abstract] [Full Text] [Related]
2. Serum metabolomic analysis of men on a low-carbohydrate diet for biochemically recurrent prostate cancer reveals the potential role of ketogenesis to slow tumor growth: a secondary analysis of the CAPS2 diet trial.
Chi JT; Lin PH; Tolstikov V; Howard L; Chen EY; Bussberg V; Greenwood B; Narain NR; Kiebish MA; Freedland SJ
Prostate Cancer Prostatic Dis; 2022 Apr; 25(4):770-777. PubMed ID: 35338353
[TBL] [Abstract] [Full Text] [Related]
3. Dosimetric impact of using a commercial metal artifact reduction tool in carbon ion therapy in patients with hip prostheses.
Zhao J; Wang W; Shahnaz K; Wu X; Mao J; Li P; Zhang Q
J Appl Clin Med Phys; 2021 Jul; 22(7):224-234. PubMed ID: 34159721
[TBL] [Abstract] [Full Text] [Related]
4. Impact of CT reconstruction algorithm on auto-segmentation performance.
Miller C; Mittelstaedt D; Black N; Klahr P; Nejad-Davarani S; Schulz H; Goshen L; Han X; Ghanem AI; Morris ED; Glide-Hurst C
J Appl Clin Med Phys; 2019 Sep; 20(9):95-103. PubMed ID: 31538718
[TBL] [Abstract] [Full Text] [Related]
5. Technical Note: Iterative megavoltage CT (MVCT) reconstruction using block-matching 3D-transform (BM3D) regularization.
Lyu Q; Yang C; Gao H; Xue Y; O'Connor D; Niu T; Sheng K
Med Phys; 2018 Jun; 45(6):2603-2610. PubMed ID: 29663467
[TBL] [Abstract] [Full Text] [Related]
6. Camptothecin and its analog SN-38, the active metabolite of irinotecan, inhibit binding of the transcriptional regulator and oncoprotein fubp1 to its DNA target sequence FUSE.
Khageh Hosseini S; Kolterer S; Steiner M; von Manstein V; Gerlach K; Trojan J; Waidmann O; Zeuzem S; Schulze JO; Hahn S; Steinhilber D; Gatterdam V; Tampé R; Biondi RM; Proschak E; Zörnig M
Biochem Pharmacol; 2017 Dec; 146():53-62. PubMed ID: 29031818
[TBL] [Abstract] [Full Text] [Related]
7. Implications of artefacts reduction in the planning CT originating from implanted fiducial markers.
Kassim I; Joosten H; Barnhoorn JC; Heijmen BJ; Dirkx ML
Med Dosim; 2011; 36(2):119-25. PubMed ID: 20435466
[TBL] [Abstract] [Full Text] [Related]
8. Tumor dosimetry on SPECT (186)Re-HEDP scans: variations in the results from the reconstruction methods used.
Divoli A; Bloch G; Chittenden S; Malaroda A; O'Sullivan JM; Dearnaley DP; Flux GD
Cancer Biother Radiopharm; 2007 Feb; 22(1):121-4. PubMed ID: 17627420
[TBL] [Abstract] [Full Text] [Related]
9. Direct-aperture optimization applied to selection of beam orientations in intensity-modulated radiation therapy.
Bedford JL; Webb S
Phys Med Biol; 2007 Jan; 52(2):479-98. PubMed ID: 17202628
[TBL] [Abstract] [Full Text] [Related]
10. Enhancing the utility of prostascint SPECT scans for patient management.
Noz ME; Chung G; Lee BY; Maguire GQ; DeWyngaert JK; Doshi JV; Kramer EL; Murphy-Walcott AD; Zeleznik MP; Kwak NG
J Med Syst; 2006 Apr; 30(2):123-32. PubMed ID: 16705997
[TBL] [Abstract] [Full Text] [Related]
11. Correction of photon attenuation and collimator response for a body-contouring SPECT/CT imaging system.
Seo Y; Wong KH; Sun M; Franc BL; Hawkins RA; Hasegawa BH
J Nucl Med; 2005 May; 46(5):868-77. PubMed ID: 15872362
[TBL] [Abstract] [Full Text] [Related]
12. Image reconstruction and the effect on dose calculation for hip prostheses.
Keall PJ; Chock LB; Jeraj R; Siebers JV; Mohan R
Med Dosim; 2003; 28(2):113-7. PubMed ID: 12804710
[TBL] [Abstract] [Full Text] [Related]
13. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET.
Etchebehere EC; Macapinlac HA; Gonen M; Humm K; Yeung HW; Akhurst T; Scher HI; Larson SM
Q J Nucl Med; 2002 Jun; 46(2):122-30. PubMed ID: 12114875
[TBL] [Abstract] [Full Text] [Related]
14. Local detection of prostate cancer by positron emission tomography with 2-fluorodeoxyglucose: comparison of filtered back projection and iterative reconstruction with segmented attenuation correction.
Turlakow A; Larson SM; Coakley F; Akhurst T; Gonen M; Macapinlac HA; Kelly W; Leibel S; Humm J; Scardino P; Scher H; Hricak H
Q J Nucl Med; 2001 Sep; 45(3):235-44. PubMed ID: 11788816
[TBL] [Abstract] [Full Text] [Related]
15. Renal clearance of the thyrotropin-releasing hormone-like peptide pyroglutamyl-glutamyl-prolineamide in humans.
Klootwijk W; Sleddens-Linkels E; de Boer R; Jansen CA; Autar R; de Herder WW; Boevé ER; Visser TJ; de Greef WJ
J Clin Endocrinol Metab; 1997 Sep; 82(9):3068-73. PubMed ID: 9284745
[TBL] [Abstract] [Full Text] [Related]
